Back | Next |
home / stock / svra / svra message board
Subject | By | Source | When |
---|---|---|---|
I think $5 break is coming right up. | Hercules1 | investorshub | 12/30/2019 8:46:10 PM |
it is going to make a run to $5. | Hercules1 | investorshub | 12/30/2019 8:36:40 PM |
WOW smoking hot on FDA approval | Rocketred | investorshub | 12/30/2019 8:32:35 PM |
here we go people: | Hercules1 | investorshub | 12/30/2019 8:25:13 PM |
Looks like there will be a short squeeze | Hercules1 | investorshub | 12/30/2019 7:46:40 PM |
This is fixing to make another explosive jump. Can | Hercules1 | investorshub | 12/30/2019 7:17:58 PM |
Glad I waited until today. | boston127 | investorshub | 12/30/2019 4:02:45 PM |
Ofcourse imo | Roadtojourney | investorshub | 12/30/2019 3:27:25 PM |
Yup sell on news pos | Roadtojourney | investorshub | 12/30/2019 3:27:04 PM |
So...looks like the co. is funded. Yes!!! | Sage7243 | investorshub | 12/30/2019 3:15:25 PM |
Well, the ol' Balls O' Steel deliver another | davidsson10 | investorshub | 12/30/2019 2:43:13 PM |
Yes, saw that earlier..... | davidsson10 | investorshub | 12/30/2019 2:17:06 PM |
Savara Announces Private Placement of $26.8 Million, With | crudeoil24 | investorshub | 12/30/2019 2:13:10 PM |
Added | Liquid1974 | investorshub | 12/30/2019 1:58:56 PM |
* * $SVRA Video Chart 11-29-2019 * * | ClayTrader | investorshub | 11/29/2019 7:40:20 PM |
powercrush86: looks like a decent entry here just from all the recent downwind. Will see how this we | powercrush86 | investorshangout | 03/30/2017 9:19:49 PM |
J Scheid: who all is playing this thing? what do you think? I don't trust the CEO. But with the merg | J Scheid | investorshangout | 02/17/2017 11:03:01 PM |
PoemStone: $MSTX climb $0.472 | PoemStone | investorshangout | 06/28/2016 10:09:01 PM |
PoemStone: $MSTX at breakout $ | PoemStone | investorshangout | 06/22/2016 2:52:18 PM |
BooDog: $MSTX time to get some game on before topline data. | BooDog | investorshangout | 06/20/2016 12:38:24 PM |
News, Short Squeeze, Breakout and More Instantly...
Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the pricing of an underwritten offering of 26,246,720 shares of its common stock at a price of $3.81 per share before deducting underwriting discounts and commissions, fo...
2024-06-27 10:15:02 ET Guggenheim analyst issues BUY recommendation for SVRA on June 27, 2024 08:56AM ET. The previous analyst recommendation was Buy. SVRA was trading at $3.84 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analy...
2024-06-27 10:00:08 ET Vamil Divan from Guggenheim issued a price target of $10.00 for SVRA on 2024-06-27 08:56:00. The adjusted price target was set to $10.00. At the time of the announcement, SVRA was trading at $3.84. The overall price target consensus is at $10.50 wi...